NEUROCRINE BIOSCIENCES INC Insider Trading for May 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEUROCRINE BIOSCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEUROCRINE BIOSCIENCES INC for May 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 19.59 | 17,486 | 342,551 | 38,568 | |
| May 29 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 80.03 | 17,486 | 1,399,434 | 141,976 | 159.5 K to 142 K (-10.97 %) |
| May 29 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 19.59 | 17,486 | 342,551 | 159,462 | 142 K to 159.5 K (+12.32 %) |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 19.59 | 1,300 | 25,467 | 56,054 | |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 80.03 | 1,300 | 104,037 | 141,976 | 143.3 K to 142 K (-0.91 %) |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 19.59 | 1,300 | 25,467 | 143,276 | 142 K to 143.3 K (+0.92 %) |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | RASTETTER WILLIAM H | Director | Option Exercise | A | 79.79 | 13,000 | 1,037,270 | 13,000 | |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | Sandrock Alfred | Director | Option Exercise | A | 79.79 | 10,000 | 797,900 | 10,000 | |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | MORROW GEORGE J | Director | Option Exercise | A | 79.79 | 10,000 | 797,900 | 10,000 | |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | LYONS GARY A | Director | Option Exercise | A | 79.79 | 10,000 | 797,900 | 10,000 | |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 79.79 | 10,000 | 797,900 | 10,000 | |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Option Exercise | A | 79.79 | 10,000 | 797,900 | 10,000 | |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 19.59 | 731 | 14,320 | 57,354 | |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.65 | 34,376 | 297,352 | 0 | |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.76 | 9,121 | 52,537 | 0 | |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 35.99 | 22,439 | 807,580 | 9,094 | |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 80.13 | 731 | 58,574 | 141,976 | 142.7 K to 142 K (-0.51 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 19.59 | 731 | 14,320 | 142,707 | 142 K to 142.7 K (+0.51 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 80.13 | 34,376 | 2,754,480 | 141,976 | 176.4 K to 142 K (-19.49 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 8.65 | 34,376 | 297,352 | 176,352 | 142 K to 176.4 K (+24.21 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 80.13 | 9,121 | 730,847 | 141,976 | 151.1 K to 142 K (-6.04 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 5.76 | 9,121 | 52,537 | 151,097 | 142 K to 151.1 K (+6.42 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 80.13 | 22,439 | 1,797,992 | 141,976 | 164.4 K to 142 K (-13.65 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 35.99 | 22,439 | 807,580 | 164,415 | 142 K to 164.4 K (+15.80 %) |
| May 15 2019 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Sell | S | 75.44 | 1,657 | 125,007 | 118,408 | 120.1 K to 118.4 K (-1.38 %) |
| May 15 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.66 | 34,547 | 299,177 | 0 | |
| May 15 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 75.51 | 34,547 | 2,608,813 | 141,976 | 176.5 K to 142 K (-19.57 %) |
| May 15 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 8.66 | 34,547 | 299,177 | 176,523 | 142 K to 176.5 K (+24.33 %) |